Probi AB Share Price

Equities

PROB

SE0001280355

Pharmaceuticals

Market Closed - Nasdaq Stockholm 08:02:17 26/04/2024 pm IST 5-day change 1st Jan Change
209 SEK +1.95% Intraday chart for Probi AB +0.97% +2.96%

Financials

Sales 2024 * 654M 59.78M 4.98B Sales 2025 * 699M 63.89M 5.33B Capitalization 2.38B 218M 18.15B
Net income 2024 * 15M 1.37M 114M Net income 2025 * 32M 2.93M 244M EV / Sales 2024 * 3.1 x
Net cash position 2024 * 355M 32.45M 2.71B Net cash position 2025 * 397M 36.29M 3.03B EV / Sales 2025 * 2.84 x
P/E ratio 2024 *
156 x
P/E ratio 2025 *
74.9 x
Employees -
Yield 2024 *
0.72%
Yield 2025 *
0.93%
Free-Float 28.27%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.95%
1 week+0.97%
Current month-0.95%
1 month+1.95%
3 months+5.03%
6 months+2.45%
Current year+2.96%
More quotes
1 week
199.00
Extreme 199
219.00
1 month
199.00
Extreme 199
224.00
Current year
181.00
Extreme 181
239.00
1 year
171.50
Extreme 171.5
239.00
3 years
165.00
Extreme 165
660.00
5 years
139.20
Extreme 139.2
660.00
10 years
39.90
Extreme 39.9
660.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 01/22/01
Director of Finance/CFO 58 01/11
Director/Board Member 44 01/14/01
Members of the board TitleAgeSince
Director/Board Member 53 13/20/13
Chairman 60 01/15/01
Director/Board Member 62 04/17/04
More insiders
Date Price Change Volume
26/24/26 209 +1.95% 170
25/24/25 205 0.00% 589
24/24/24 205 +0.49% 292
23/24/23 204 0.00% 114
22/24/22 204 -1.45% 795

Delayed Quote Nasdaq Stockholm, April 26, 2024 at 08:02 pm IST

More quotes
Probi AB is a Sweden-based company engaged in the probiotics research and development. The Company’s activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi probiotics in collaboration with a range of entities, such as pharmaceutical companies and firms related to the production of probiotics and self-care goods. Its brands portfolio comprises two trademarks: Probi Digestis and Probi Defendum. The Company's partners include Danone, Skanemejerier, NextFoods, Sanum Polska, Heinz, Kraft Foods, and Institut Rosell, among others. The Company is a parent of Probi Food AB and Probi Feed AB.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings